ANATOMY OF A FAILURE TO LAUNCH: BARRIERS TO GENERIC MARKET ENTRY AND THE USE OF COMPETITION LAW AS A REMEDY
Section
Health & Consumers
Event Description
The webinar will be the occasion for the launch of a White Paper entitled “Anatomy of a failure to launch: A review of barriers to generic and biosimilar entry and the use of competition law”.
The discussion will focus on how to make sure that current barriers to generic and biosimilar medicines market entry can be tackled in order to avoid any unnecessary delays to patient access.
The launch of the White Paper aims to inform the current debate around the IP strategy in the context of the broader Pharmaceutical Strategy of the European Commission. Discussions will include how to deal with IP and patent quality, patent linkage, pricing strategies, as well as ways to ensure effective competition in the pharmaceutical market.
Events of the week
Jobs
FENS - Federation of European Neuroscience Societies
E.DSO
SolarPower Europe
RE-Source Platform
Acumen Public Affairs
NATO Parliamentary Assembly
SolarPower Europe
European Principal Traders Association (FIA EPTA)
Hanns-Seidel-Stiftung
EURACTIV News
- Alcohol is a public health challenge. Why don’t we see it that way? [Advocacy Lab Content]
- Kazakhstan investing in renewables, hydrocarbons, and infrastructure with new energy vision [Advocacy Lab Content]
- Europe’s start-up ecosystem is evolving, with big investment returns now possible [Advocacy Lab Content]
- Climate change slowly killing Europe’s beech forests, says new study [Advocacy Lab Content]
- Albania shuts down TikTok at least for a year